Skip to content


  • Case report
  • Open Access
  • Open Peer Review

Mycoplasma hominis brain abscess presenting after a head trauma: a case report

  • 1Email author,
  • 1,
  • 2 and
  • 1
Journal of Medical Case Reports20126:253

  • Received: 20 March 2012
  • Accepted: 8 June 2012
  • Published:
Open Peer Review reports



Mycoplasma hominis brain abscess is a rare occurrence, and treatment is not well defined. The mechanism by which M. hominis infects sites outside the genitourinary tract, including the central nervous system, is unclear.

Case presentation

We report the case of a 40-year-old Somali man who sustained a traumatic brain injury that required initial neurosurgical hematoma evacuation and that subsequently was complicated by a hospital-acquired M. hominis brain abscess. Our patient was successfully treated with neurosurgical debridement and an antibiotic course of intravenous doxycycline.


Head trauma or neurosurgical procedures or both might be a predisposing factor for this type of infection.


  • Doxycycline
  • Clindamycin
  • Bacterial Vaginosis
  • Subdural Hematoma
  • Brain Abscess


Mycoplasma hominis is generally a genitourinary (GU) pathogen. M. hominis brain abscess is rare. To the best of our knowledge, only ten cases have been reported in the literature. However, the true incidence may be higher than this because the organism is difficult to grow in vitro. Optimal treatment of M. hominis brain abscess is not well defined in the literature. The organism is uniformly resistant to macrolides, and other potentially useful agents do not penetrate the central nervous system well.

Case presentation

A previously healthy 40-year-old Somali man presented after a motor vehicle accident. Injuries included a right subdural hematoma, subarachnoid hemorrhages, intra-parenchymal contusions, facial fractures, and a left humerus fracture. The subdural hematoma was evacuated by means of a craniotomy on hospital day 7. On hospital day 13, our patient developed a fever of 39. 2 °C and purulent drainage from the craniotomy wound. A computed tomography (CT) scan of his head without intravenous contrast demonstrated multiple foci of gas-containing abscesses along the margin of the craniotomy (Figure 1a). The air in the abscess was considered part of the expected post-craniotomy changes. Incision, drainage, and removal of the bone flap were promptly performed. Vancomycin and piperacillin/tazobactam were initiated and then narrowed to ceftriaxone and metronidazole when a Gram stain revealed many polymononuclear cells but no organisms. Despite this management, fevers continued and our patient’s mental status failed to improve. A CT scan of his head without intravenous contrast on hospital day 20 revealed an increase in both the size and extent of the brain abscess (Figure 1a). Our patient underwent a second debridement; again a Gram stain revealed no organisms. A pathology examination of the brain abscess showed a cerebral abscess in the superior temporal lobe with necrosis but without organisms (Figure 1d).
Figure 1
Figure 1

CT images and Pathology description: (a) Multiple foci of gas-containing abscesses along the margin of the craniotomy (arrow). (b) Significant increase in the size and extent of the brain abscess (arrow). (c) Resolving brain swelling and abscess. (d) Cerebral abscess in the superior temporal lobe with necrosis, newly formed capillaries, and scattered fibroblasts. The inflammatory infiltrate includes neutrophils, lymphocytes, plasma cells, and histiocytes (stain: hematoxylin and eosin; magnification: ×400).

Cultures on sheep’s blood agar from the neurosurgical debridements revealed small colonies with a peripheral clearing (‘fried egg’ morphology). Through sequencing of the 16 S ribosomal subunit region at a reference laboratory, the isolate was identified as M. hominis with 100% homology to reference strains. Our patient’s antibiotics were changed to doxycycline 100mg intravenously twice per day on hospital day 24. His mental status and fevers improved significantly. The abscess had almost fully resolved by hospital day 40 (Figure 1c).


M. hominis is traditionally considered to be a GU pathogen and has been implicated in non-gonococcal urethritis and post-partum fevers and is a possible cause of bacterial vaginosis [1, 2]. In addition to causing infection, M. hominis is well known to colonize the GU and respiratory tracts [35]. M. hominis infections outside the GU tract are uncommon, but the organism has been isolated in cases of bacteremia, inguinal wound infections, sternotomy infection, septic prosthetic hip arthritis, pleural empyema, ventriculo-peritoneal shunt infections, and post-neurosurgical wound infections [6].

Eleven cases of M. hominis brain abscess [715], including this case, have been published (Table 1). Eight of these cases were related to head trauma or craniotomy. The mean time to M. hominis isolation in the published literature is 13.5 days, suggesting that patients acquire M. hominis brain abscess while in the hospital. Hemorrhagic lesions in the brain could be seeded by contiguous infection after disruption of a colonized upper airway following trauma or after transient bacteremia from manipulation of the colonized oropharyngeal or GU tracts or both.
Table 1

Cases of adult Mycoplasma hominis brain abscess



Age and sex

Associated condition

First culture after AD




29-year-old man

Head trauma

21 days




20-year-old man

Head trauma

14 days

Cefotaxime + metronidazole + doxycycline



22-year-old woman


8 days

Ceftriaxone + metronidazole



40-year-old woman

Cavernous angioma/craniotomy

4 days

Ciprofloxacin + metronidazole



17-year-old girl


13 days

Doxycycline + clindamycin



40-year-old man

Head trauma

14 days




17-year-old girl

Head trauma

17 days




48-year-old man

Craniotomy for colloid cyst removal

18 days

Gatifloxacin + clindamycin


2003/ 2006







40-year-old man

Head trauma

13 days


aPresent report. AD: admission day; NA: not available.

M. hominis is uniformly resistant to macrolides. Fluoroquinolones, tetracyclines, and clindamycin have better in vitro antimicrobial activity against M. hominis [16, 17]. These three classes of antibiotics possess similar, moderate rates of blood–brain barrier penetration [18]. Rates of in vitro resistance to these antibiotics may be as high as 10% for clindamycin, 27% for doxycycline, and 80% for ciprofloxacin. However, there have been successful reports for each of these therapies.


M. hominis brain abscess is rare. The mechanism of M. hominis brain abscess is likely to be either direct spread from a colonized oropharynx to an open head wound or seeding of an intra-cranial hematoma from transient bacteremia after manipulation of the GU tract. M. hominis brain abscesses are treatable with surgical drainage and appropriate antimicrobial therapy of a tetracycline, clindamycin, or fluoroquinolone.




computed tomography





No funding agencies had a role in the preparation, review, or approval of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the views of the University of Colorado Denver.

Authors’ Affiliations

Department of Medicine, Division of Infectious Diseases, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO 80045, USA
Department of Pathology, University of Colorado Denver, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO 80045, USA


  1. Kilic D, Basar MM, Kaygusuz S, Yilmaz E, Basar H, Batislam E: Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis. Jpn J Infect Dis. 2004, 57: 17-20.PubMedGoogle Scholar
  2. Germain M, Krohn MA, Hillier SL, Eschenbach DA: Genital flora in pregnancy and its association with intrauterine growth retardation. J Clin Microbiol. 1994, 32: 2162-2168.PubMedPubMed CentralGoogle Scholar
  3. Clegg A, Passey M, Yoannes M, Michael A: High rates of genital mycoplasma infection in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J Clin Microbiol. 1997, 35: 197-200.PubMedPubMed CentralGoogle Scholar
  4. Mufson MA: Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans. Sex Transm Infect. 1983, 10: 335-340.Google Scholar
  5. Lusk MJ, Konecny P, Naing ZW, Garden FL, Cumming RG, Rawlinson WD: Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sex Transm Infect. 2011, 87: 107-109. 10.1136/sti.2010.045138.View ArticlePubMedGoogle Scholar
  6. Madoff S, Hooper DC: Nongenitourinary infections caused by Mycoplasma hominis in adults. Rev Infect Dis. 1988, 10: 602-613. 10.1093/clinids/10.3.602.View ArticlePubMedGoogle Scholar
  7. Payan DG, Seigal N, Madoff S: Infection of a brain abscess of Mycoplasma hominis. J Clin Microbiol. 1981, 14: 571-573.PubMedPubMed CentralGoogle Scholar
  8. Kersten RC, Haglund L, Kulwin DR, Ma’luf R, DeConciliis C: Mycoplasma hominis orbital abscess. Arch Ophthalmol. 1995, 113: 1096-1097. 10.1001/archopht.1995.01100090018009.View ArticlePubMedGoogle Scholar
  9. Zheng X, Olson DA, Tully JG, Watson HL, Cassell GH, Gustafson DR, Svien KA, Smith TF: Isolation of Mycoplasma hominis from a brain abscess. J Clin Microbiol. 1997, 35: 992-994.PubMedPubMed CentralGoogle Scholar
  10. House P, Dunn J, Carroll K, MacDonald J: Seeding of a cavernous angioma with Mycoplasma hominis: case report. Neurosurgery. 2003, 53: 749-752. 10.1227/01.NEU.0000080064.21806.28. discussion 752–743View ArticlePubMedGoogle Scholar
  11. Douglas MW, Fisher DA, Lum GD, Roy J: Mycoplasma hominis infection of a subdural haematoma in the peripartum period. Pathology. 2003, 35: 452-454. 10.1080/00313020310001602684.View ArticlePubMedGoogle Scholar
  12. Kupila L, Rantakokko-Jalava K, Jalava J, Peltonen R, Marttila RJ, Kotilainen E, Kotilainen P: Brain abscess caused by Mycoplasma hominis: a clinically recognizable entity?. Eur J Neurol. 2006, 13: 550-551. 10.1111/j.1468-1331.2006.01209.x.View ArticlePubMedGoogle Scholar
  13. McCarthy KL, Looke DF: Successful treatment of post-neurosurgical intracranial Mycoplasma hominis infection using gatifloxacin. J Infect. 2008, 57: 344-346. 10.1016/j.jinf.2008.06.022.View ArticlePubMedGoogle Scholar
  14. Kupila L, Rantakokko-Jalava K, Jalava J, Nikkari S, Peltonen R, Meurman O, Marttila RJ, Kotilainen E, Kotilainen P: Aetiological diagnosis of brain abscesses and spinal infections: application of broad range bacterial polymerase chain reaction analysis. J Neurol Neurosurg Psychiatry. 2003, 74: 728-733. 10.1136/jnnp.74.6.728.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Al Masalma M, Armougom F, Scheld WM, Dufour H, Roche PH, Drancourt M, Raoult D: The expansion of the microbiological spectrum of brain abscesses with use of multiple 16 S ribosomal DNA sequencing. Clin Infect Dis. 2009, 48: 1169-1178. 10.1086/597578.View ArticlePubMedGoogle Scholar
  16. Krausse R, Schubert S: In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect. 2010, 16: 1649-1655. 10.1111/j.1469-0691.2010.03155.x.View ArticlePubMedGoogle Scholar
  17. McCormack WM: Susceptibility of mycoplasmas to antimicrobial agents: clinical implications. Clin Infect Dis. 1993, 17 (Suppl 1): S200-S201.View ArticlePubMedGoogle Scholar
  18. Nau R, Sorgel F, Eiffert H: Penetration of drugs through the blood-cerebrospinal fluid/blood–brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010, 23: 858-883. 10.1128/CMR.00007-10.View ArticlePubMedPubMed CentralGoogle Scholar


© Henao-Martínez et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.